Remuneration

Fiscal year 2025-2026

1. Total annual spending on remuneration paid to full-time permanent employees was $18,968,234 for the calendar year ended December 31, 2025.

2. Total number of full-time permanent employees as of March 31, 2026, is 130. On occasion, temporary contracts are leveraged to support workload.

3. Total compensation for the calendar year ended December 31, 2025 (as reported on 2025 T4) for the following employees:

Title Remuneration (2025 T4 slips) Taxable benefits (included in remuneration figure)
Chief Executive Officer $784,688.71 $4,404.48
VP, Finance & Corporate Services $303,404.79 $4,800.83
VP, Strategic Partnerships $319,411.10 $4,800.83
*VP, Cancer Systems and Innovation $263,266.06 $3,794.73
**Acting VP, Cancer Systems and Innovation $222,420.64 $3,404.08

*On leave for part of 2025 (compensation reported includes leave entitlements)
**Acting VP role for leave coverage (includes incumbent’s Director level salary for part of 2025)

4. Partnership staff salary ranges (in effect as of March 31, 2026):

Level Position Annual remuneration range Number of full-time permanent
employees
9 Director $131,895 – $202,753 11
8 Controller, Enterprise Architect $120,936 – $166,466 2
7 Manager, Sr. HR Business Partner, Program Manager, Lead $100,780 – $138,721 29
6 Analyst, Program Manager, Service Manager, Lead, Specialist, Advisor, Senior Accountant, Web Developer, Project Manager $80,624 – $109,080 56
5 Analyst, Officer, Executive Assistant to CEO, Executive Assistant to VP, Finance & Corporate Services/Board Liaison, Executive Assistant to VP, Cancer Systems and Innovation and VP, Strategic Partnerships $70,723 – $95,683 14
4 Coordinator $54,419 – $73,626 10
3 Administrative Assistant $47,736 – $64,584 4
    TOTAL 130*

*Includes 126 employees and 4 executives

5. Total remuneration paid to Partnership Board members for the year ended December 31, 2025 (as reported to Revenue Canada on 2025 T4 slips) was $107,000.

Partnership remuneration